The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review

Mol Neurobiol. 2023 Nov;60(11):6383-6394. doi: 10.1007/s12035-023-03469-7. Epub 2023 Jul 15.

Abstract

Neurological diseases place a substantial burden on public health and have a serious impact on the quality of life of patients. Despite the multifaceted pathological process involved in the occurrence and development of these neurological diseases, each disease has its own unique pathological characteristics and underlying molecular mechanisms which trigger their onset. Thus, it is unlikely to achieve effective treatment of neurological diseases by means of a single approach. To this end, we reason that it is pivotal to seek an efficient strategy that implements multitherapeutic targeting and addresses the multifaceted pathological process to overcome the complex issues related to neural dysfunction. In recent years, natural medicinal plant-derived monomers have received extensive attention as new neuroprotective agents for treatment of neurological disorders. Fisetin, a flavonoid, has emerged as a novel potential molecule that enhances neural protection and reverses cognitive abnormalities. The neuroprotective effects of fisetin are attributed to its multifaceted biological activity and multiple therapeutic mechanisms associated with different neurological disorders. In this review article, we summarize recent research progression regarding the pharmacological effects of fisetin in treating several neurological diseases and the potential mechanisms.

Keywords: Fisetin; Nerve injury; Neurological diseases; Neuroprotection; Pharmacological treatment.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Flavonols
  • Humans
  • Nervous System Diseases* / drug therapy
  • Neuroprotection
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Quality of Life

Substances

  • fisetin
  • Flavonols
  • Flavonoids
  • Neuroprotective Agents